ROYAL BANK OF CANADA - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 188 filers reported holding REPLIGEN CORP in Q3 2015. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2023$17,559,000
+13.1%
110,426
+0.6%
0.01%
+25.0%
Q2 2023$15,526,000
-15.1%
109,763
+1.1%
0.00%
-20.0%
Q1 2023$18,285,000
+63.6%
108,615
+64.6%
0.01%
+66.7%
Q4 2022$11,175,000
-15.8%
66,007
-7.0%
0.00%
-25.0%
Q3 2022$13,273,000
+7.9%
70,941
-6.4%
0.00%0.0%
Q2 2022$12,303,000
-5.2%
75,760
+9.8%
0.00%
+33.3%
Q1 2022$12,978,000
-30.9%
69,004
-2.7%
0.00%
-25.0%
Q4 2021$18,786,000
-19.0%
70,929
-11.6%
0.00%
-33.3%
Q3 2021$23,198,000
+29.3%
80,272
-10.7%
0.01%
+20.0%
Q2 2021$17,938,000
+18.3%
89,865
+15.2%
0.01%
+25.0%
Q1 2021$15,169,000
+8.7%
78,032
+7.1%
0.00%0.0%
Q4 2020$13,959,000
+33.7%
72,842
+2.9%
0.00%0.0%
Q3 2020$10,438,000
+4.2%
70,760
-12.7%
0.00%0.0%
Q2 2020$10,015,000
-0.2%
81,022
-22.1%
0.00%
-20.0%
Q1 2020$10,038,000
-23.6%
103,986
-26.8%
0.01%0.0%
Q4 2019$13,133,000
+70.4%
141,991
+41.3%
0.01%
+66.7%
Q3 2019$7,708,000
+4.7%
100,507
+17.3%
0.00%0.0%
Q2 2019$7,363,000
+84.1%
85,663
+26.6%
0.00%
+50.0%
Q1 2019$3,999,000
+14.9%
67,678
+2.5%
0.00%0.0%
Q4 2018$3,481,000
+2.0%
65,996
+7.3%
0.00%
+100.0%
Q3 2018$3,412,000
+55.7%
61,533
+32.0%
0.00%0.0%
Q2 2018$2,192,000
+60.9%
46,618
+23.8%
0.00%0.0%
Q1 2018$1,362,000
+9.0%
37,642
+9.3%
0.00%0.0%
Q4 2017$1,249,000
-18.8%
34,434
-14.3%
0.00%0.0%
Q3 2017$1,539,000
+5.6%
40,180
+14.3%
0.00%0.0%
Q2 2017$1,457,000
+13.3%
35,146
-3.8%
0.00%0.0%
Q1 2017$1,286,000
+17.6%
36,518
+2.9%
0.00%0.0%
Q4 2016$1,094,000
-29.1%
35,475
-30.6%
0.00%0.0%
Q3 2016$1,544,000
+65.8%
51,114
+50.1%
0.00%0.0%
Q2 2016$931,000
+68.7%
34,044
+65.4%
0.00%
Q1 2016$552,000
-5.8%
20,579
-0.7%
0.00%
Q4 2015$586,000
+10.6%
20,714
+9.0%
0.00%
Q3 2015$530,000
-29.0%
18,997
+5.0%
0.00%
-100.0%
Q2 2015$747,000
+9.4%
18,098
-19.6%
0.00%
Q1 2015$683,000
-9.8%
22,500
-41.1%
0.00%
Q4 2014$757,000
-28.2%
38,225
-27.8%
0.00%
-100.0%
Q3 2014$1,054,000
-71.3%
52,925
-67.2%
0.00%
-50.0%
Q2 2014$3,672,000
+666.6%
161,125
+332.3%
0.00%
Q1 2014$479,000
+16.5%
37,275
+23.6%
0.00%
Q4 2013$411,000
+6750.0%
30,159
+5633.7%
0.00%
Q3 2013$6,000
+500.0%
526
+426.0%
0.00%
Q2 2013$1,0001000.00%
Other shareholders
REPLIGEN CORP shareholders Q3 2015
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders